CAR-T therapy-based innovations in the enhancement of contemporary anti-tumor therapies
Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized the treatment landscape for hematologic malignancies; however, its efficacy in solid tumors remains limited due to antigen heterogeneity, a suppressive tumor microenvironment, and tumor-intrinsic resistance mechanisms. In parallel,...
Saved in:
Main Authors: | Wan-Ying Zhang, Lang-Yu Yang, Xing-Xing Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1622433/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation
by: Xiangyun Niu, et al.
Published: (2025-07-01) -
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies
by: Liu X, et al.
Published: (2025-06-01) -
From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors
by: Mégane Jassin, et al.
Published: (2025-07-01) -
Resistance Mechanisms to BCMA Targeting Bispecific Antibodies and CAR T-Cell Therapies in Multiple Myeloma
by: Brandon Tedder, et al.
Published: (2025-07-01) -
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy
by: Wuyuan Liao, et al.
Published: (2025-07-01)